What is Galmed Pharmaceuticals Ltd?
a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases and related indications.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases and related indications. The company develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule which is in a Phase III study for oral treatment for non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 4.95M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.